NKX2-1 and lung adenocarcinoma: In previous work, we and others have shown that loss of NKX2-1 is sufficient to cause lineage switching in a mouse model of KRASG12D-driven lung adenocarcinoma (Maeda et al., 2011; Snyder et al., 2013; Tata et al., 2018).